Skip to main content
  • Newsletters
  • Axios Pro
  • Axios Live
  • The Axios Show
Axios

Axios

Katherine Davis

Katherine Davis is a biotech reporter for Axios Pro Deals. She reports on venture capital, private equity and M&A transactions across the biotech sector.

  • email[email protected]

Stories

    • Biotech Deals

    14 hours ago

    Slate Medicines raises $130M for migraine, headache therapies

    Go deeper (1 min. read)
    • Health Tech Deals

    Feb 23, 2026

    Signs of an AI bubble emerge across health care

    Go deeper (2 min. read)
    • Biotech Deals

    Feb 23, 2026

    Generate Biomedicines seeks up to $425M in IPO

    Go deeper (1 min. read)
    • Biotech Deals

    Feb 23, 2026

    Gilead to buy Arcellx for $7.8B

    Go deeper (1 min. read)
    • Biotech Deals

    Feb 19, 2026

    Crowell & Moring attorney: FDA whiplash fuels biotech uncertainty

    Go deeper (1 min. read)

Newsletter editions

    • Newsletter

    Feb 23, 2026

    💭 Thought bubble: In-house threat

    Go deeper (2 min. read)
    • Newsletter

    Feb 21, 2026

    🧬 Biotech weekly

    Go deeper (3 min. read)
    • Newsletter

    Feb 14, 2026

    🧬 Biotech weekly

    Go deeper (3 min. read)
    • Newsletter

    Feb 11, 2026

    💭 Thought bubble: Shot clock ticking

    Go deeper (2 min. read)
    • Newsletter

    Feb 7, 2026

    🧬 Biotech weekly

    Go deeper (3 min. read)
Smarter, faster on what matters.
Explore Axios Newsletters
  • About Axios
  • Advertise with us
  • Careers
  • Contact us
  • Newsletters
  • Axios Live
  • Axios HQ
  • Privacy policy
  • Terms of use
Axios Homepage

Axios Media Inc., 2026